Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

July 31, 2031

Study Completion Date

July 31, 2031

Conditions
Urothelial Bladder Cancer
Interventions
RADIATION

Experimental arm

Consolidative radiotherapy (pelvic irradiation and/or metastases irradiation) + standard of care +/- previous transurethral resection of bladder tumor

Trial Locations (20)

Unknown

RECRUITING

Clinique Claude Bernard, Albi

RECRUITING

Institut de Cancerologie de L'Ouest, Angers

RECRUITING

CHU Besançon, Besançon

RECRUITING

Institut Bergonie, Bordeaux

RECRUITING

CHRU Brest, Brest

RECRUITING

Clinique Pasteur-Lanroze, Brest

RECRUITING

Centre Francois Baclesse, Caen

WITHDRAWN

Centre Jean Perrin, Clermont-Ferrand

RECRUITING

Institut Andrée Dutreix, Dunkirk

WITHDRAWN

Centre Oscar Lambret, Lille

RECRUITING

Institut Paoli-Calmettes, Marseille

RECRUITING

Centre Antoine Lacassagne, Nice

NOT_YET_RECRUITING

Groupe Hospitalier Paris Saint-Joseph, Paris

RECRUITING

Institut Curie, Paris

WITHDRAWN

Groupement de Radiothérapie et d'Oncologie des Pyrénées, Pau

RECRUITING

Institut de Cancerologie de L'Ouest, Saint-Herblain

RECRUITING

HIA Bégin, Saint-Mandé

NOT_YET_RECRUITING

Institut de Cancerologie Lucien Neuwirth, Saint-Priest-en-Jarez

RECRUITING

Institut Universitaire du Cancer Toulouse Oncopole, Toulouse

RECRUITING

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER